We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

1 hedge funds and large institutions have $0 invested in Arena Pharmaceuticals Inc in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 312 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 316 → 1 (-315)

100% less funds holding in top 10

Funds holding in top 10: 7 → 0 (-7)

100% less capital invested

Capital invested by funds: $4.86B → $0 (-$4.86B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 312

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-315
Holders Change %
-99.68%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
312
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$530M
2
BlackRock
BlackRock
New York
-$452M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$361M
4
State Street
State Street
Massachusetts
-$213M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$167M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
201
Centiva Capital
New York
– -$850K -9,144 Closed
MAM
202
Martingale Asset Management
Massachusetts
– -$829K -8,914 Closed
Arrowstreet Capital
203
Arrowstreet Capital
Massachusetts
– -$812K -8,732 Closed
AB
204
Amalgamated Bank
New York
– -$767K -8,251 Closed
MTCM
205
Mint Tower Capital Management
Netherlands
– -$750K -8,072 Closed
Public Employees Retirement Association of Colorado
206
Public Employees Retirement Association of Colorado
Colorado
– -$737K -7,927 Closed
Zurich Cantonal Bank
207
Zurich Cantonal Bank
Switzerland
– -$713K -7,671 Closed
SSG
208
Summit Securities Group
New York
– -$706K -7,600 Closed
NSEDCP
209
NJ State Employees Deferred Compensation Plan
New Jersey
– -$669K -7,200 Closed
SO
210
STRS Ohio
Ohio
– -$669K -7,200 Closed
Commonwealth Equity Services
211
Commonwealth Equity Services
Massachusetts
– -$649K -6,984 Closed
Simplex Trading
212
Simplex Trading
Illinois
– -$643K -6,927 Closed
Envestnet Asset Management
213
Envestnet Asset Management
Illinois
– -$644K -6,925 Closed
HWAM
214
Hennion & Walsh Asset Management
New Jersey
– -$613K -6,600 Closed
DIA
215
Dana Investment Advisors
Wisconsin
– -$558K -6,007 Closed
Ohio Public Employees Retirement System (OPERS)
216
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$558K -6,000 Closed
AG
217
Algert Global
California
– -$551K -5,930 Closed
KPF
218
K2 Principal Fund
Ontario, Canada
– -$502K -5,400 Closed
Stifel Financial
219
Stifel Financial
Missouri
– -$491K -5,286 Closed
TRCT
220
Tower Research Capital (TRC)
New York
– -$492K -5,285 Closed
CSS
221
Cubist Systematic Strategies
Connecticut
– -$490K -5,269 Closed
SAM
222
Shell Asset Management
Netherlands
– -$485K -5,216 Closed
DA
223
DCF Advisers
Connecticut
– -$465K -5,000 Closed
KWMG
224
King Wealth Management Group
Florida
– -$465K -5,000 Closed
AIP
225
Ameritas Investment Partners
Nebraska
– -$448K -4,824 Closed
7 8
9
10 11

ARNA Hedge Fund Activity: Q1 2022 in Review

1 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q1 2022, worth a combined $0 — down 100% from $4.86B a quarter earlier.

Sellers outnumbered buyers: 312 funds closed out of ARNA and 0 opened new positions — a net loss of 312 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $530M sold.

  • 1 institutional investor held Arena Pharmaceuticals Inc (ARNA) as of Q1 2022, down from 316 in Q4 2021.
  • Funds reported $0 of Arena Pharmaceuticals Inc stock for Q1 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Arena Pharmaceuticals Inc positions in Q1 2022 and 312 closed out, a net change of -312 holders.
  • The largest Arena Pharmaceuticals Inc seller in Q1 2022 was Vanguard Group, an estimated $530M sold.

Based on aggregated 13F filings for Q1 2022.